The publication of this announcement is required by The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Securities and Futures Commission (the "SFC") solely for the purpose of providing information to the public in Hong Kong. By viewing this announcement, you acknowledge, accept and agree with the Company, its joint sponsors, overall coordinators, advisors or members of the underwriting syndicate that: 1 (a) the publication of this announcement on the Stock Exchange's website does not giv ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Axera Semiconductor Co., Ltd. 愛芯元智半導體股份有限公司 (the "Company") (A joint stock comp ...

As filed with the Securities and Exchange Commission on January 23, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OPTION THERAPEUTICS INC. (Exact name of registrant as specified in its charter) | | | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 680 W Nye Lane, Suite 201 Carson ...

As filed with the Securities Exchange Commission on January 23, 2026 Registration Statement No. 333-______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (State or other jurisdiction of incorporation or organization) Delaware 3690 84-3628771 (I.R.S. Employer Identification No.) 250 Technology Park Lake Mary, FL 32046 (407) 804-1000 (Address, including zip code, and telephone number, including area code, of registrant's ...

As filed with the Securities and Exchange Commission on January 23, 2026. Registration Statement No. 333-292131 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ Delaware 2834 87-3198325 (State or other jurisdiction of in ...

As filed with the Securities and Exchange Commission on January 23, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AKARI THERAPEUTICS, PLC (Exact name of registrant as specified in its charter) England and Wales 2834 98-1034922 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code) (I.R.S. Employer Identification No.) 401 East Jackson ...

As filed with the Securities and Exchange Commission on January 23, 2026. Registration No. 333-291904 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 United Acquisition Corp. I (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Paul Packer Chief Executive Officer 7100 W. Camino Real, Suite 302-48 Boca Raton, Florida 33433 212-847-3248 ...

As filed with the U.S. Securities and Exchange Commission on January 23, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form S-1 (406) 718-7593 (Address, including zip code and telephone number, including area code, of registrant's principal executive offices) C T Corporation System 1015 15th Street N.W., Suite 1000 Washington, DC 20005 (202) 572-3100 (Name, address, including zip code, and telephone number, including area code, of agent for service) REGISTRATION STATEMENT UNDE ...

As filed with the Securities and Exchange Commission on January 23, 2026 Registration No. 333-292711 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) FORM S-1 REGISTRATION STATEMENT 17130 N. Dallas Parkway, Suite 240 Dallas, Texas 75248 (214 ...

Registration No. 333-290834 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Public Policy Holding Company, Inc. (Exact Name of Registrant as Specified in its Charter) (Primary Standard Industrial Delaware 8742 87-3557229 (I.R.S. Employer Identification Number) 800 North Capitol St. NW, Suite 800 Washington, D.C. 20002 (202) 688–0020 As filed with the Securities and Exchange Commission on January 23, 2 ...